ADAMS W ANDREW - 09 May 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Reporting relationship: Director
Issuer ticker: NHC
Reported as of: 09 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 May 2024, 17:23:46 UTC
Prior SEC filing: 09 May 2024
Next SEC filing: 03 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ W. Andrew Adams

Key filing fact

ADAMS W ANDREW filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 13 May 2024.

Key facts

This page summarizes ADAMS W ANDREW's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
1 reported transaction and 5 derivative rows are listed below.
Accepted by SEC: 13 May 2024, 17:23.

Change

Previous filing in this sequence was filed on 09 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHC holding

Shares of Common Stock - WAA Exempt Trust

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 399,929
Date: 09 May 2024
Ownership: Direct

NHC holding

Shares of Common Stock - Revocable Living Trust

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 262,072
Date: 09 May 2024
Ownership: Direct

NHC holding

Shares of Common Stock - Adams Family Foundation II

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 35,407
Date: 09 May 2024
Ownership: Trustee

NHC holding

Shares of Common Stock - Adams Grandchildren's Trust

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,307
Date: 09 May 2024
Ownership: Trustee

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHC transaction Derivative

Option to Purchase Common Stock [2024 Grant]

Award

Transaction value: $0
Shares: +7,500
Change %
Price: $0.000000
Shares after: 7,500
Date: 09 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $96.03
Footnotes: F1

NHC holding Derivative

Option to Purchase Common Stock [2020 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 09 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $64.64

NHC holding Derivative

Option to Purchase Common Stock [2021 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 09 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $71.64

NHC holding Derivative

Option to Purchase Common Stock [2022 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 09 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $69.19

NHC holding Derivative

Option to Purchase Common Stock [2023 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 09 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $55.75

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).